missing translation for 'onlineSavingsMsg'
Learn More
Learn More
EpCAM/TROP1 Antibody (EGP40/1798), CoraFluor™ 1, Novus Biologicals™
Mouse Monoclonal Antibody
Marca: Novus Biologicals NBP2-54456CL1
Código de producto. 30153656
-
1175.00€
1108.80€ / 0.10 ml
Ahorro 66.20€
5% Descuento
Por favor, inicie sesión para comprar este producto. ¿No tiene usuario web? Regístrese hoy mismo.
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
EpCAM/TROP1 Monoclonal antibody specifically detects EpCAM/TROP1 in Canine,Feline,Human samples. It is validated for Flow Cytometry,ELISA,Immunohistochemistry,Western Blot,Immunohistochemistry (Paraffin),Protein Array,CyTOF,Immunocytochemistry/Immunofluorescence
Especificaciones
| EpCAM/TROP1 | |
| Monoclonal | |
| CoraFluor 1 | |
| 17-1A, 323/A3, ACSTD1, antigen identified by monoclonal AUA1, CD326 antigen, Cell surface glycoprotein Trop-1, chromosome 4, surface marker (35kD glycoprotein), DIAR5, EGP, EGP-2, EGP314, EGP40, EpCAM, epithelial cell adhesion molecule, Epithelial cell surface antigen, Epithelial glycoprotein, Epithelial glycoprotein 314, ESA, GA733-2EGP34, hEGP314, HNPCC8, KS 1/4 antigen, KS1/4, KSAHEA125, M1S2, M4S1Ly74, Major gastrointestinal tumor-associated protein GA733-2, MIC18MH99, MOC31, TACST-1, TACSTD1, TROP1CD326, Tumor-associated calcium signal transducer 1CO-17A | |
| Recombinant fragment from the extracellular domain of human EpCAM/TROP1 protein (around aa100-224) (exact sequence is proprietary) (Uniprot: P16422 ) | |
| 0.1 mL | |
| Cancer, Cancer Stem Cells, Tumor Biomarkers | |
| 4072 | |
| Store at 4°C in the dark. Do not freeze. | |
| IgG2b κ |
| Flow Cytometry, ELISA, Immunohistochemistry, Western Blot, Immunohistochemistry (Paraffin) | |
| EGP40/1798 | |
| PBS | |
| Mouse | |
| Protein A or G purified | |
| RUO | |
| Primary | |
| Canine, Feline, Human | |
| Purified |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido